Prognostic value of JAK3 promoter methylation and mRNA expression in clear cell renal cell carcinoma

Long Qian, Chunyu Huang, Jinsheng Huang, Meng Qi, Yanjun Cheng, Yilin Li, Liru He, Miao Chen, Changlin Zhang, Xiaonan Wang, Wancui Zhu, Peng Jin, Dingbo Shi, Fufu Zheng, Pei Dong, Wuguo DengJournal of Advanced Research 2021 · DOI

Abstract

Our data demonstrated that the crucial role of JAK3 promoter methylation in its expression regulation and tumor microenvironment. JAK3 promoter methylation and expression are associated with clinicopathological characteristics, overall survival, and immune cell infiltration in ccRCC. We propose a rationale for further validation of JAK3 promoter methylation as a molecular biomarker for predicting responses to immune checkpoint inhibitors in ccRCC.
BibTeX
@article{qian2021prognostic,
  author = {Long Qian and Chunyu Huang and Jinsheng Huang and Meng Qi and Yanjun Cheng and Yilin Li and Liru He and Miao Chen and Changlin Zhang and Xiaonan Wang and Wancui Zhu and Peng Jin and Dingbo Shi and Fufu Zheng and Pei Dong and Wuguo Deng},
  title = {{Prognostic value of JAK3 promoter methylation and mRNA expression in clear cell renal cell carcinoma}},
  journal = {Journal of Advanced Research},
  year = {2021},
  doi = {10.1016/j.jare.2021.11.016},
}

Loading related content...

Figure